Skip To Main Content
Chad R Ritch on Muck Rack

Chad R Ritch

United States
As seen in: Nature, The BMJ, Medscape, UroToday, Urologic Clinics of North America, Archives of Pathology, Urology Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chad R

Contact Chad R, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Surveillance Protocols Balancing Patient Burden and Cancer Control

|
By Jessica Delgado, Chad R Ritch, Heather Steckenrider
| Urologic Clinics of North America Verified
Keywords Surveillance Bladder cancer Superficial Get full text access Log in, subscribe or purchase for full access. References 1. Holzbeierlein, J.M. ∙ Holmes, R. ∙ James, A.C. ... AUA/-SUO guideline: 2024 amendment J Urol. 2024; 211(4):533-538 2. Gontero, P. ∙ Birtle, A. ∙ Capoun, O. ... European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-a summary of the 2024 guidelines update Eur Urol. 2024; 86(6):531-549 3.
Open in Who Shared Issue with article?

4K density: Adjusting the 4Kscore for prostate volume to improve risk stratification of clinically significant prostate cancer in men undergoing prostate biopsy | Prostate Cancer and Prostatic Diseases Original

|
By Pedro Freitas, Chad R Ritch, Timothy Guerard
| Nature Verified
Abstract The 4K Score is a blood-based test that estimates the risk of clinically significant prostate cancer (Grade Group ≥2, GG2 + ) by combining four kallikrein markers with clinical variables. However, benign prostatic hyperplasia (BPH) can elevate PSA levels, potentially leading to risk overestimation in men with large prostates. We developed a novel metric, 4K Density (4K Score divided by prostate volume), to adjust for prostate size and improve risk stratification.
Open in Who Shared View Duplicates (2) Issue with article?

Racial and ethnic differences in valuation of life expectancy in prostate cancer treatment decision making - Prostate Cancer and Prostatic Diseases

|
By John M. Masterson, Renning Zheng, Adam Murphy, Chad R Ritch, Stephen J. Freedland
| Nature Verified
Abstract Life expectancy (LE) is essential for triage between aggressive and conservative management for all prostate cancer risk subtypes. We sought to investigate differences in how Black and Hispanic men interpret LE in treatment decision-making. We used targeted crowdsourcing to sample a cohort reflecting sociodemographics of a US prostate cancer population.
Open in Who Shared Issue with article?
See all 8 licensed articles (24 Total)